נורמלקס
taro pharmaceutical industries ltd - polyethylene glycol 3350 - אבקה להכנת תמיסה - polyethylene glycol 3350 100 %w/w - osmotically acting laxatives - for the treatment of constipation.
נורמלקס קידס
taro pharmaceutical industries ltd - polyethylene glycol 3350 - אבקה להכנת תמיסה - polyethylene glycol 3350 4 g - macrogol
רופפין טבליות
kamada ltd, israel - rupatadine as fumarate - טבליה - rupatadine as fumarate 10 mg - rupatadine
רופפין תמיסה לשתייה 1 מגמל
kamada ltd, israel - rupatadine as fumarate - תמיסה - rupatadine as fumarate 1 mg / 1 ml - rupatadine
גזים איקס
cts chemical industries ltd, israel - simethicone - טבליה - simethicone 125 mg - combinations of complexes of aluminium, calcium and magnesium compound - antiflatulence.
סימיקול טבליות
cts chemical industries ltd, israel - simethicone - טבליה - simethicone 125 mg - combinations of complexes of aluminium, calcium and magnesium compound - antiflatulence.
רטרוביר קפסולות 100 מג
glaxo smith kline (israel) ltd - zidovudine - קפסולות - zidovudine 100 mg - zidovudine - zidovudine - retrovir oral formulations are indicated in anti-retroviral combination therapy for human immunodeficiency virus (hiv) infected adults and children.retrovir chemoprophylaxis is indicated for use in hiv-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal hiv transmission and for primary prophylaxis of hiv infection in newborn infants.
רטרוביר קפסולות 250 מג
glaxo smith kline (israel) ltd - zidovudine - קפסולות - zidovudine 250 mg - zidovudine - zidovudine - retrovir oral formulations are indicated in anti-retroviral combination therapy for human immunodeficiency virus (hiv) infected adults and children.retrovir chemoprophylaxis is indicated for use in hiv-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal hiv transmission and for primary prophylaxis of hiv infection in newborn infants.
קומביויר
glaxo smith kline (israel) ltd - lamivudine; zidovudine - טבליות מצופות פילם - lamivudine 150 mg; zidovudine 300 mg - lamivudine - lamivudine - combivir is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.
רפמיון תמיסה
pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus - sirolimus - rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. it is recommended that rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.